news aktuell GmbHnews aktuell GmbH

Leading mobility platform FREE NOW and micro-mobility provider TIER announce strategic partnership across Europe

Share

Hamburg/Berlin, March 9 2021 - FREE NOW 

TIER e-scooter and e-moped services will be integrated into the FREE NOW app

  • Micro-mobility provider TIER will make all its electric scooters and mopeds available in Germany and France in the FREE NOW app. Both companies are eager to increase the scope in the future.
  • From April 2021 onwards, the partnership will start with the launch in eight German cities followed by France shortly afterwards. Further cities across Europe will be launched throughout the summer.

FREE NOW, Europe’s leading multi-mobility platform, and TIER, Europe’s leading provider of micro-mobility with a mission to change mobility for good, announced today that they have signed a strategic partnership. From April onwards, TIER e-scooters and e-mopeds will be available to book via the FREE NOW app. The partnership will launch in eight German cities, shortly followed by France. Further cities across Europe will be launched throughout the summer.

With this deal, thousands of e-scooters and e-mopeds will be bookable via the FREE NOW app. In demonstration of both companies’ commitment to sustainability, TIER will take over 5,000 FREE NOW e-scooters, rebranding them to TIER and adding them to their fleet. For both companies, greener travel is at the core: not only are both climate-neutral, they focus on the most eco-friendly mobility options in support of the Paris Climate Agreement.

Lawrence Leuschner, co-founder and CEO of TIER, said: “Our mission to change mobility for good is largely about creating strong partnerships to expand everyone's access to sustainable, easily accessible and multimodal mobility solutions. Teaming up with one of Europe’s leading mobility platforms will allow us to expand access to our micro-mobility services in Germany, France and other European countries.”

Marc Berg, CEO of FREE NOW, added: “Our partnership with TIER is a great demonstration of how committed FREE NOW is to being a multi mobility platform. It is our mission to empower smarter mobility decisions, help people to move freely and cities to thrive – we are looking forward to bringing even more sustainable e-scooter options to cities all across Europe. The availability of TIER e-scooters and e-mopeds in our app shows that consumers need one app to book all their services to move from A to B. We will make this possible together with TIER and will broaden our scope of multi mobility offerings massively in the future.”

About FREE NOW

FREE NOW is the multi-mobility joint venture backed by BMW Group and Daimler AG. Next to ride hailing, FREE NOW also offers micro-mobility services such as e-scooters, e-bikes, e-vespas as well as car sharing. It consists of the services FREE NOW (10 European markets) and Βeat (5 Latin American and 1 European market). Summed up, those services currently attract 50 million users in 16 markets and more than 150 cities. FREE NOW is therefore the biggest multi-service mobility provider in Europe and the fastest-growing ride-hailer in Latin America. FREE NOW works with various third party providers to offer their customers an even wider range of options to get from A to B. In total, around 2,000 employees in around 35 offices work for the services of FREE NOW, which is led by CEO Marc Berg.

About TIER Mobility
TIER Mobility is Europe's leading provider of micro-mobility with a mission to change mobility for good.

The company is a driving force behind the change in the transport sector, which aims to significantly reduce car traffic in cities by providing people with a wide range of electric vehicles.

As part of its commitment to sustainability, the company has adopted the United Nations' Sustainable Development Goals (SDGs) as a guiding framework and has set a clear agenda for reducing and offsetting emissions. As a result of these measures, TIER Mobility has been a climate-neutral company since January 2020.

TIER Mobility operates in 90+ cities in 10 countries. The company is headquartered in Berlin and employs about 900 people. Founders of the company are Lawrence Leuschner, Matthias Laug. and Julian Blessin.

The company's investors are SoftBank Vision Fund 2, Mubadala Investment Company’s financial investment arm, Mubadala Capital, Northzone, Goodwater Capital, White Star Capital, Novator, RTP Global, Speedinvest and many more.

For more information about TIER Mobility, please visit www.tier.app. You can find more pictures here.

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

ARD Presse: CIVIS MEDIA PRIZE 2021 - 23 productions nominated, 5 podcasts for the public vote15.4.2021 11:22:26 CEST | Press release

(Cologne, Germany): CIVIS Media Prize 2021 – The 23 nominees of what is Europe's most important media prize when it comes to integration and cultural diversity have been selected: Candidates for the CIVIS Media Prize include entries from ARTE, Bayerischer Rundfunk, Filmakademie Baden-Württemberg, FYEO, HBO, Mitteldeutscher Rundfunk, Norddeutscher Rundfunk, Österreichischer Rundfunk, ProSieben, Radio Bremen, Saarländischer Rundfunk, Schweizer Radio und Fernsehen, Südwestrundfunk, Westdeutscher Rundfunk and ZDF. The productions deal with highly topical issues such as flight, racism, right-wing extremism and antisemitism in many different ways; however, they also cover strategies against hate and violence as well as strategies for the peaceful coexistence of people with diverse geographical and cultural origins. Nearly 800 productions from television, radio and the Internet were submitted for the CIVIS Competition 2021. They came from 20 EU states and Switzerland. The complete list of nom

Grünenthal Group: Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee12.4.2021 11:47:13 CEST | Press release

With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain related to osteoarthritis of the knee. MTX-071 (resiniferatoxin) is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist. Its administration can reversibly defunctionalise TRPV1-expressing nociceptors. This can result in long lasting pain relief. (Aachen, Germany) –Today, Grünenthal has announced the acquisition of Mestex AG through the takeover of all of its shares and options. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III. Initial data showed a long-lasting and significant analgesic effect and function

Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry12.4.2021 09:00:00 CEST | Press release

IRVINE, CA., April 12, 2021 – Fluxergy, Inc., a medical diagnostic testing platform company with a detection technology solution capable of multimodality, announced today that it has obtained CE marking for its one-hour COVID-19 RT-PCR test, to use by healthcare professionals as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2. The CE-mark will allow Fluxergy’s innovative testing platform to enter the European Union market and any other markets that accept CE-marking as valid regulatory approval. Fluxergy’s platform is an automated, sample-to-answer testing platform with multimodal capability allowing for a variety of assay types, such as molecular, immunochemistry, chemistry, and cytometry assays, to be run simultaneously on the same cartridge. This will give users the ability to run unique Point-of-Care (PoC) panels with the potential ability to do built-in reflex testing, among other capabilities. Potential environments for rapid testing applications include emergency ro

Grunenthal Group: Grünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks7.4.2021 11:39:12 CEST | Press release

• Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry • Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies like Pfizer and Roche (Aachen, Germany): Grünenthal, a global science-based pharmaceutical company, today announced that Sustainalytics, a Morningstar company and a globally-recognized provider of ESG research, ratings and data, has assessed it as having overall medium ESG risk. In addition, Sustainalytics acknowledged that Grünenthal has a strong management of its ESG risks. This places Grünenthal in the top five percent of the global pharmaceuticals subsector. “The long-term success of companies can no longer be measured by financial success alone. As a science-based company, Grünenthal strives to make a net-positive impact on the society,” said Gabriel Baertschi, CEO Grünenthal. “While we are proud to

DocMorris: Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life6.4.2021 09:15:56 CEST | Press release

The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with obesity a new way to find the right care. Adipositas Care thoughtfully empowers people living with obesity by enabling them to learn about obesity and discover possible care solutions, to link to specialized advisors, doctors and digital solutions in obesity care, and by supporting them with the testimonials of peers who took action to better manage their health, all within one digital location. The program launches today in Germany with the intention to expand across other European markets.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom